Allyson Berent (Part 2) | 2022 FAST Summit on Angelman Syndrome скачать в хорошем качестве

Allyson Berent (Part 2) | 2022 FAST Summit on Angelman Syndrome

Allyson Berent, DVM, DACVIM | FAST Chief Science Officer Angelman Syndrome Biomarker and Outcome Measure Consortium: What's the Hype? Why Does It Matter So Much? For more information, visit https://cureangelman.org This recording is sponsored by FAST Australia Recorded December 2, 2022 in Miami, Florida Disclaimer: The information contained in these slides and video is provided for informational purposes only and should not be construed as medical, legal, financial, or any other type of professional advice. The content is subject to change without notice and is not intended to be relied upon as definitive guidance. The information contained was accurate as of the date of preparation; however, please note that some data, facts and figures may have changed or become outdated if reviewed after the presentation date. FAST makes no commitment to update this content and advises viewers to verify information for its current relevance. These slides and video and all associated intellectual property are the exclusive property of the Foundation for Angelman Syndrome Therapeutics. Unauthorized modification, reproduction, translation, or distribution of any part of these slides and video is strictly prohibited.